Skip to main content

Advertisement

Figure 2 | BMC Medicine

Figure 2

From: Corticortophin releasing factor 2 receptor agonist treatment significantly slows disease progression in mdx mice

Figure 2

Histomorphological analysis of diaphragm muscle from mdx mice treated with vehicle, prednisone, PG-87367 and PG-873637+prednisone for 3 months. Three-month-old mdx mice were treated by daily subcutaneous injection with the indicated compounds for 3 months and at the end of treatment, the diaphragms were removed and a histomorphological analysis performed. Time 0, 3 month old mdx mice before treatment. Vehicle, mdx mice treated for 3 months with vehicle. Prednisone, mdx mice treated for 3 months with 1 mg/kg of prednisone. PG-873637, mdx mice treated for 3 months with 30 ug/kg of PG-873637. PG-873637 + prednisone, mdx mice treated for 3 months with the combination of 30 ug/kg PG-873637 plus 1 mg/kg prednisone. The two photographs in each treatment group are from representative diaphragm sections from two different animals in each treatment group. All samples were hematoxylin and eosin stained.

Back to article page